<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - Cephalon</title>
<description>International Business News - Cephalon</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>Cephalon spent nearly $516K lobbying gov't in 2Q</title>
  <description>Biotech drugmaker Cephalon spent nearly $516,000 lobbying the federal government in the second quarter, according to a recent disclosure form. The Frazer, Pa.-based company lobbied on a range of bills affecting the development, sales and marketing of prescription drugs, according to a form filed July 21 with the House clerk's office.</description>
    <link>http://www.ibtimes.com/articles/20080812/cephalon-spent-nearly-516k-lobbying-govt-in-2q.htm</link> 
  <pubDate>Tue, 12 Aug 2008 09:59:56 EDT</pubDate>
  </item>


  <item>
  <title>Outlook roundup: Cephalon, Electronic Arts</title>
  <description>Among the earnings projection stories for Tuesday, July 29, from AP Financial News: FRAZER, Pa. (AP)--Biotechnology company Cephalon Inc. on Tuesday raised its outlook for the full fiscal year after posting second-quarter profit results that beat Wall Street expectations.</description>
    <link>http://www.ibtimes.com/articles/20080729/outlook-roundup-cephalon-electronic-arts.htm</link> 
  <pubDate>Tue, 29 Jul 2008 18:07:35 EDT</pubDate>
  </item>


  <item>
  <title>Cephalon raises full-year guidance on strong 2Q</title>
  <description>Biotechnology company Cephalon Inc. on Tuesday raised its outlook for the full fiscal year after posting second-quarter profit results that beat Wall Street expectations.</description>
    <link>http://www.ibtimes.com/articles/20080729/cephalon-raises-full-year-guidance-on-strong-2q.htm</link> 
  <pubDate>Tue, 29 Jul 2008 17:32:50 EDT</pubDate>
  </item>


  <item>
  <title>Cephalon swings to 2Q profit</title>
  <description>Biotechnology company Cephalon Inc. said Tuesday it swung to a profit in the second quarter, helped by brisk sales of central nervous system drugs and of new drugs it didn't offer last year.</description>
    <link>http://www.ibtimes.com/articles/20080729/cephalon-swings-to-2q-profit.htm</link> 
  <pubDate>Tue, 29 Jul 2008 17:27:12 EDT</pubDate>
  </item>


  <item>
  <title>Barr challenges Cephalon pain-drug patent</title>
  <description>Drug developer Barr Pharmaceuticals Inc. said Thursday it is challenging Cephalon Inc.'s patent on the pain drug Fentora and in turn is being sued to prevent it from marketing a generic version.</description>
    <link>http://www.ibtimes.com/articles/20080724/barr-challenges-cephalon-pain-drug-patent.htm</link> 
  <pubDate>Thu, 24 Jul 2008 16:18:08 EDT</pubDate>
  </item>


  <item>
  <title>Cephalon drug prompts response in cancer study</title>
  <description>Biotechnology company Cephalon Inc. said Tuesday its leukemia drug Treanda, in combination with Genentech Inc.'s Rituxan, prompted a response in non-Hodgkin's lymphoma patients during a midstage study.</description>
    <link>http://www.ibtimes.com/articles/20080715/cephalon-drug-prompts-response-in-cancer-study.htm</link> 
  <pubDate>Tue, 15 Jul 2008 10:18:16 EDT</pubDate>
  </item>


  <item>
  <title>Analysts see higher drug sales for Cephalon</title>
  <description>Sales of Cephalon Inc.&amp;#39;s muscle relaxant Amrix and cancer treatment Treanda will likely continue to drive revenue for the Frazer, Pa.-based drug developer, several analysts said Friday.</description>
    <link>http://www.ibtimes.com/articles/20080620/analysts-see-higher-drug-sales-for-cephalon.htm</link> 
  <pubDate>Fri, 20 Jun 2008 12:18:01 EDT</pubDate>
  </item>


  <item>
  <title>Cephalon spent $512,000 on lobbying in first quarter</title>
  <description>Biotech drugmaker Cephalon spent more than $512,000 lobbying the federal government in the first quarter, according to a government disclosure form. Cephalon lobbied in favor of more funding for the Food and Drug Administration, which reviews the safety of all new medicines in the U.S.</description>
    <link>http://www.ibtimes.com/articles/20080516/cephalon-spent-512-000-on-lobbying-in-first-quarter.htm</link> 
  <pubDate>Fri, 16 May 2008 12:41:55 EDT</pubDate>
  </item>


  <item>
  <title>Ahead of the Bell: FDA rejects new label for Cephalon drug</title>
  <description>A Food and Drug Administration panel voted against broadening the label for Cephalon Inc.&amp;#39;s pain drug Fentora, but analysts said Wednesday the drug may eventually be approved to treat non-cancer pain.</description>
    <link>http://www.ibtimes.com/articles/20080507/ahead-of-the-bell-fda-rejects-new-label-for-cephalon-drug.htm</link> 
  <pubDate>Wed, 07 May 2008 07:17:50 EDT</pubDate>
  </item>


  <item>
  <title>FDA panel rejects Cephalon pain drug on risks of misuse</title>
  <description>Medical experts on Tuesday voted against wider approval of a powerful painkiller made by Cephalon Inc., saying it could worsen existing misuse of the drug that has caused overdose and death.</description>
    <link>http://www.ibtimes.com/articles/20080506/fda-panel-rejects-cephalon-pain-drug-on-risks-of-misuse.htm</link> 
  <pubDate>Tue, 06 May 2008 16:08:52 EDT</pubDate>
  </item>


  <item>
  <title>Ahead of the Bell: Cephalon drug gets FDA panel review</title>
  <description>Medical experts will consider Tuesday whether use of a painkiller made by Cephalon Inc. should be expanded, despite government concerns about increased risks for abuse.</description>
    <link>http://www.ibtimes.com/articles/20080506/ahead-of-the-bell-cephalon-drug-gets-fda-panel-review.htm</link> 
  <pubDate>Tue, 06 May 2008 06:26:44 EDT</pubDate>
  </item>


  <item>
  <title>Cephalon shares fall ahead of FDA panel on pain drug Fentora</title>
  <description>Cephalon Inc. shares fell Friday over concerns that the biotechnology company may face a tougher-than-expected Food and Drug Administration panel review next week for its cancer pain drug Fentora.</description>
    <link>http://www.ibtimes.com/articles/20080502/cephalon-shares-fall-ahead-of-fda-panel-on-pain-drug-fentora.htm</link> 
  <pubDate>Fri, 02 May 2008 12:38:27 EDT</pubDate>
  </item>


  <item>
  <title>FDA says wider use of Cephalon drug carries risks of misuse</title>
  <description>Government regulators on Friday said encouraging wider use of a powerful painkiller made by Cephalon Inc. raises the risk of potentially fatal misuse of the drug.</description>
    <link>http://www.ibtimes.com/articles/20080502/fda-says-wider-use-of-cephalon-drug-carries-risks-of-misuse.htm</link> 
  <pubDate>Fri, 02 May 2008 12:26:06 EDT</pubDate>
  </item>


  <item>
  <title>Cephalon gets notice of Watson challenge of Fentora patent</title>
  <description>Shares of Cephalon Inc. dipped Thursday after the drugmaker said rival Watson Laboratories Inc. has filed to sell a generic version of its Fentora pain medication, but analysts shrugged off the potential competition.</description>
    <link>http://www.ibtimes.com/articles/20080424/cephalon-gets-notice-of-watson-challenge-of-fentora-patent.htm</link> 
  <pubDate>Thu, 24 Apr 2008 13:26:17 EDT</pubDate>
  </item>


  <item>
  <title>Cephalon CEO Gets $16M Compensation</title>
  <description>Drugmaker Cephalon Inc. disclosed Monday that it awarded nearly $16 million in compensation to its chief executive in 2007, a hefty reward from a midsize business.</description>
    <link>http://www.ibtimes.com/articles/20080324/cephalon-ceo-gets-16m-compensation.htm</link> 
  <pubDate>Mon, 24 Mar 2008 19:26:23 EDT</pubDate>
  </item>


  <item>
  <title>Cephalon Director Exercises Options</title>
  <description>A director with biotechnology company Cephalon Inc. exercised options for 10,000 shares of common stock, according to a Securities and Exchange Commission filing.</description>
    <link>http://www.ibtimes.com/articles/20080311/cephalon-director-exercises-options.htm</link> 
  <pubDate>Tue, 11 Mar 2008 14:39:34 EDT</pubDate>
  </item>


  <item>
  <title>Cephalon Accused of Blocking Generics</title>
  <description>Federal regulators sued Cephalon Inc. on Wednesday, accusing the company of illegally blocking the sale of low-cost generics to protect its biggest money making drug.</description>
    <link>http://www.ibtimes.com/articles/20080213/cephalon-accused-of-blocking-generics.htm</link> 
  <pubDate>Wed, 13 Feb 2008 19:21:59 EST</pubDate>
  </item>


  <item>
  <title>Cephalon Hits Year Low Despite '08 Hopes</title>
  <description>Shares of Cephalon Inc. jumped, then dove to a new year low Wednesday after Wall Street noted a surprising fourth quarter for the biotechnology company and shifted focus to possible future revenue drivers.</description>
    <link>http://www.ibtimes.com/articles/20080213/cephalon-hits-year-low-despite-08-hopes.htm</link> 
  <pubDate>Wed, 13 Feb 2008 18:40:50 EST</pubDate>
  </item>


  <item>
  <title>FTC Sues Cephalon Over Settlements</title>
  <description>The Federal Trade Commission on Wednesday accused biotechnology company Cephalon Inc. of buying off possible generic competition to its sleep disorder treatment, according to a federal lawsuit.</description>
    <link>http://www.ibtimes.com/articles/20080213/ftc-sues-cephalon-over-settlements.htm</link> 
  <pubDate>Wed, 13 Feb 2008 18:28:31 EST</pubDate>
  </item>


  <item>
  <title>Cephalon Shares Rise on 2008 Hopes</title>
  <description>Shares of Cephalon Inc. jumped Wednesday as Wall Street noted a surprising fourth quarter for the biotechnology company and shifted focus to possible future revenue drivers.</description>
    <link>http://www.ibtimes.com/articles/20080213/cephalon-shares-rise-on-2008-hopes.htm</link> 
  <pubDate>Wed, 13 Feb 2008 12:20:50 EST</pubDate>
  </item>


</channel>
</rss>